DEEPIKA PAKIANATHAN - 26 Feb 2026 Form 4 Insider Report for Mereo BioPharma Group plc (MREO)

Role
Director
Signature
/s/ Christine Fox, by power of attorney
Issuer symbol
MREO
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
27 Feb 2026, 16:30:13 UTC
Previous filing
29 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PAKIANATHAN DEEPIKA Director C/O MEREO BIOPHARMA GROUP PLC, 4TH FLOOR, ONE CAVENDISH PLACE, LONDON, UNITED KINGDOM /s/ Christine Fox, by power of attorney 27 Feb 2026 0001270734

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MREO Share Options (Right to buy) Award $0 +66,000 $0.000000 66,000 26 Feb 2026 American Depositary Shares 66,000 $0.3900 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.
F2 Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.